Nicolas Kiavué

844 total citations
13 papers, 363 citations indexed

About

Nicolas Kiavué is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nicolas Kiavué has authored 13 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Nicolas Kiavué's work include Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (5 papers). Nicolas Kiavué is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (5 papers). Nicolas Kiavué collaborates with scholars based in France, United States and Belgium. Nicolas Kiavué's co-authors include François‐Clément Bidard, Jean‐Yves Pierga, Luc Cabel, Antoine Vasseur, Florence Lerebours, Guillaume Bataillon, Céline Callens, Samia Melaabi, Delphine Loirat and Paul Cottu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Nicolas Kiavué

12 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Kiavué France	10	257	179	110	110	37	13	363
Robert Konschak Germany	9	241 0.9×	189 1.1×	120 1.1×	102 0.9×	33 0.9×	12	397
Anne Renolen Norway	9	385 1.5×	252 1.4×	110 1.0×	98 0.9×	49 1.3×	13	468
José Roberto Freitas Rossari Belgium	6	273 1.1×	157 0.9×	68 0.6×	107 1.0×	32 0.9×	8	329
Annkathrin Hanssen Germany	7	339 1.3×	243 1.4×	114 1.0×	167 1.5×	45 1.2×	10	439
C. P. Carden United Kingdom	6	213 0.8×	139 0.8×	104 0.9×	140 1.3×	30 0.8×	8	358
L Ryvo Israel	5	462 1.8×	140 0.8×	95 0.9×	173 1.6×	20 0.5×	8	544
Hanne Lind United States	5	336 1.3×	134 0.7×	150 1.4×	128 1.2×	13 0.4×	7	496
Joke Tommelein Belgium	6	244 0.9×	118 0.7×	127 1.2×	44 0.4×	38 1.0×	7	359
Xianjing Chu China	7	201 0.8×	61 0.3×	127 1.2×	100 0.9×	37 1.0×	12	399
Simonetta M. Leto Italy	6	380 1.5×	134 0.7×	126 1.1×	151 1.4×	28 0.8×	9	492

Countries citing papers authored by Nicolas Kiavué

Since Specialization

Citations

This map shows the geographic impact of Nicolas Kiavué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Kiavué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Kiavué more than expected).

Fields of papers citing papers by Nicolas Kiavué

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Kiavué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Kiavué. The network helps show where Nicolas Kiavué may publish in the future.

Co-authorship network of co-authors of Nicolas Kiavué

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Kiavué. A scholar is included among the top collaborators of Nicolas Kiavué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Kiavué. Nicolas Kiavué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Djerroudi, Lounes, Toulsie Ramtohul, Enora Laas, et al.. (2025). Clinico-pathological factors predicting pathological response in early triple-negative breast cancer. npj Breast Cancer. 11(1). 15–15. 10 indexed citations

Bidard, François‐Clément, Frédérique Berger, Mónica Arnedos, et al.. (2024). Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial.. Journal of Clinical Oncology. 42(16_suppl). TPS1139–TPS1139. 1 indexed citations

Loirat, Delphine, Nicolas Kiavué, Diana Bello Roufai, et al.. (2024). Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases. Breast Cancer. 31(4). 572–580. 11 indexed citations

Pierga, Jean‐Yves, et al.. (2024). Circulating tumor cells in breast cancer: clinical validity and utility. npj Breast Cancer. 10(1). 103–103. 9 indexed citations

Bidard, François‐Clément, Nicolas Kiavué, William Jacot, et al.. (2023). Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial. Journal of Clinical Oncology. 42(4). 383–389. 28 indexed citations

Bidard, François‐Clément, Nicolas Kiavué, Catherine Alix‐Panabières, et al.. (2023). Abstract GS3-09: GS3-09 Circulating Tumor Cells-driven choice of first line therapy for ER+ HER2- metastatic breast cancer: overall survival analysis of the randomized STIC CTC trial. Cancer Research. 83(5_Supplement). GS3–9.

Loirat, Delphine, et al.. (2023). 216P Sacituzumab govitecan in metastatic triple-negative breast cancer: Efficacy -with a focus on brain metastases- and toxicity in a real-world cohort. ESMO Open. 8(1). 101405–101405. 2 indexed citations

Stern, Marc‐Henri, Nicolas Kiavué, Luc Cabel, et al.. (2022). Microsatellite instability detection in breast cancer using drop-off droplet digital PCR. Oncogene. 41(49). 5289–5297. 12 indexed citations

Cabel, Luc, Frédérique Berger, Paul Cottu, et al.. (2021). Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial. British Journal of Cancer. 124(7). 1207–1213. 47 indexed citations

10.

Cabel, Luc, Florence Lerebours, Delphine Loirat, et al.. (2020). Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy. Breast Cancer Research. 22(1). 98–98. 19 indexed citations

11.

Vasseur, Antoine, Nicolas Kiavué, François‐Clément Bidard, Jean‐Yves Pierga, & Luc Cabel. (2020). Clinical utility of circulating tumor cells: an update. Molecular Oncology. 15(6). 1647–1666. 141 indexed citations

12.

Kiavué, Nicolas, Luc Cabel, Samia Melaabi, et al.. (2019). ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics. Oncogene. 39(3). 487–502. 74 indexed citations

13.

Verret, Benjamin, Charles Honoré, Sarah Dumont, et al.. (2016). Trabectedin in advanced desmoplastic round cell tumors. Anti-Cancer Drugs. 28(1). 116–119. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact